Navigation Links
CuraGen Advances CR011-vcMMAE into Phase II
Date:4/9/2008

ghts and uncertainties relating to commercialization rights, as well as those risks, uncertainties and factors referred to in CuraGen's Annual Report on Form 10-K for the year ended December 31, 2007, filed with the Securities and Exchange Commission under the section "Risk Factors," as well as other documents that may be filed by CuraGen from time to time with the Securities and Exchange Commission. As a result of such risks, uncertainties and factors, CuraGen's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward- looking statements contained herein. CuraGen is providing the information in this press release as of this date and assumes no obligations to update the information included in this press release or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Glenn Schulman, PharmD

Director of Medical Communications

gschulman@curagen.com

(888) 436-6642

CRGN-P


'/>"/>
SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
2. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
3. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
4. CuraGen Announces Top-Line Phase II Results on Velafermin
5. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
6. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
7. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
8. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
9. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
10. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
11. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2009)...RNewswire-FirstCall/ -- Sangamo BioSciences, Inc. ...rch milestone has been achieved in its Research an...-owned member of the Roche Group, for the generati...armaceutical protein production purposes using San... nuclease (ZFN) technology. Genentech scientists d...
(Date:6/26/2009)...d OSAKA, Japan, June 27, 2009 Take... announced that Takeda Global Research & Devel...(U.S.) subsidiary received on June 26 (U.S. time) ...Drug Administration (FDA) regarding the Company,s ...tive dipeptidyl peptidase IV (DPP-4) inhibitor und...
(Date:6/26/2009)...nd New Genetic Mutations Acting Together-- , , ...ore pieces in the complex autism inheritance puzzl... team including geneticists from The Children,s Ho...vania School of Medicine and several collaboratin... genetic regions where rare copy number variations...
(Date:6/25/2009)...e-USNewswire/ -- As of mid-2009, The Michael J. Fo...funded over $1 million in high-risk, high-reward a...hrough its groundbreaking Rapid Response Innovati... safety and efficacy of an FDA-approved drug for k...on of a tenuous link between PD and certain strain...
Breaking Medicine Technology:Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 32007 hurricane forecasts took blow from winds and Saharan dry dusty air 4510 12007 hurricane forecasts took blow from winds and Saharan dry dusty air 4510 22007 hurricane forecasts took blow from winds and Saharan dry dusty air 4510 3The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 25516 1The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 25516 2The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 25516 3Emerging Growth Equities Ltd Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an 2418 00 Price Target 7204 1Emerging Growth Equities Ltd Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an 2418 00 Price Target 7204 2Older Patients Less Likely to Be Taken to Trauma Centers 25508 1Older Patients Less Likely to Be Taken to Trauma Centers 25508 2Older Patients Less Likely to Be Taken to Trauma Centers 25508 3
..., 2007 - According to,The Waismann Method 2006 Opi...ents seeking treatment for opiate dependency have ... OxyContin, Percocet,and Fentanyl were among the d... who reported a dependency said they suffered from...ed addiction,specialist for the Waismann Method., ...
...herapies to Prevent,and Reverse Atherosclerotic He...ewswire/ -- KineMed, Inc.,a pathway-based drug di...he first method for measuring the efflux of choles...known as reverse cholesterol,transport (RCT). RCT ...terol can be removed from tissues and has therefor...
Other Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3
(Date:7/4/2009)...ets are tight, experts say, health and fitness nee...lthDay News) -- Most people are cutting back in th...make do with less. But can you cut back when it co...say you can -- if you,re smart about it. There are...healthily, staying physically fit and receiving ne...
(Date:7/3/2009)...Hungary, July 3 Bertalan Mesko, me... a free e-guide for medical professionals focu...cine. Medical conferences are expensive and patien...tion. This eGuide helps doctors enter a virtual re...s for free as Second Life provides opportunities f...
(Date:7/3/2009)..., July 3 Republicans on...uage in health care reform legislation that would ...happens, many women could lose coverage for aborti... includes. Plus, millions of uninsured women will ...ing been promised a better quality of life. , ,...
(Date:7/3/2009)... ReverseAges.com launches new content t...drenal fatigue, and how to best deal with these he... CA (PRWEB) July 3, 2009 -- ReverseAges.com has re... explain the dangers of common health issues such ...sed by a variety of factors, and the new content o...
Breaking Medicine News(10 mins):Health News:Living Healthily on Less 2Health News:Living Healthily on Less 3Health News:Living Healthily on Less 4
...een signal to a drug produced in the milk of genet...retrograde to a budding industry that sought to en...mals GTC Biotherapeutics, proponents of this dru..., expressing their opinion that the verdict came a...
...Nigeria has forced the import of nearly 1 million ...y farmers in Nigeria would soon receive their shar...selves against the deadly infection. Bird flu has...s, according to official reports. No case of human...
...l of Medical Research has announced the installati...s by ICMR in Chennai// , New Delhi, Kolkata and Pu... international consultancy firm will be in charge ...inning from Rs 15 crores to Rs 20 crores, with an ...
... platinum and gold in the treatment of autoimmune ...treatment of rheumatoid arthritis and other autoim...w been found that platinum or gold can prevent the...us) from taking hold of an important immune system...
Other Medicine News:Health News:Regulators Object Drug Produced from Genetically Engineered Farm Animals 2
...ted DNA and RNA from agarose gels to hybridization...peed and efficiency of transfer by allowing high p...d system allowing electrophoresis, gel treatment, ...29 hours required for conventional methods ,Positi...
...ted DNA and RNA from agarose gels to hybridization...peed and efficiency of transfer by allowing high p...d system allowing electrophoresis, gel treatment, ...29 hours required for conventional methods ,Positi...
Trans-Blot Plus Gel/Cassette Assembly Tray
PosiBlot 30-30 Masks
Medicine Products: